XJPX
2373
Market cap36mUSD
Oct 09, Last price
425.00JPY
1D
0.95%
1Q
5.99%
Jan 2017
-66.98%
IPO
-70.69%
Name
Care Twentyone Corp
Chart & performance
P/E
14.96
P/S
0.12
EPS
28.41
Div yield, %
4.04%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
7.22%
Revenues
48.16b
+6.08%
Net income
384m
+37.98%
CFO
2.17b
+205.90%
Dividend
Oct 29, 202610 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Care Twentyone Corporation operates as a comprehensive welfare company in Japan. The company offers home care, paid nursing home, dementia group home, in-home care support, small-scale multi-functional home care, day service, and welfare equipment rental/home renovation services. It also provides support services for people with disabilities; and childcare, home nursing care, home nursing care, medical support, acupuncture and massage, human resource placement and dispatch, lifestyle support, dinning, real estate, and Type A and Type B continuous employment support, as well as employment services for people with disabilities. In addition, the company operates nursing qualification training schools. Care Twentyone Corporation was incorporated in 1993 and is headquartered in Osaka, Japan.
Key people
Koji Yamada
Senior Chief Director Operation, Director of Finance and Accounting, Director of Business Planning, Director of Human Resource Recruitment , Director of Human Resource Planning, Director · since 2025
Katsuhiro Hashiyama
Chief Director of Welfare Business, Director · since 2025
Kikei Teshiro
Director · since 2025
Taira Yoda
Chairman of the Board, Representative Director · since 2022
Masashi Yoda
President, Chief Director of Business Strategy, President of Subsidiary, Representative Director · since 2022
Toru Fukagai
Independent Director · since 2006
Gyoji Ishida
Independent Director · since 2020
Ichiro Kitaura
Independent Director · since 2021
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑10 | 2024‑10 | 2023‑10 | 2022‑10 | 2021‑10 | 2020‑10 | 2019‑10 | 2018‑10 | 2017‑10 | 2016‑10 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||